In our study, we assessed the expression of IFI30 in ccRCC using various databases, including The Cancer Genome Atlas (TCGA) and the Human Protein Atlas (HPA) to obtain clinical information, and understand its relationship with the overall survival (OS) of ccRCC individuals. The gene discussed is IFI30; the disease is nonpapillary renal cell carcinoma.